Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: Perspective for SARS vaccine development
Publication in refereed journal


Times Cited
Web of Science14WOS source URL (as at 31/07/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractBackground: The S (spike) protein of the etiologic coronavirus (CoV) agent of severe acute respiratory syndrome (SARS) plays a central role in mediating viral infection via receptor binding and membrane fusion between the virion and the host cell. We focused on using synthetic peptides for developing antibodies against SARS-CoV, which aimed to block viral invasion by eliciting an immune response specific to the native SARS-CoV S protein.
All Author(s) ListChoy WY, Lin SG, Chan PKS, Tam JSL, Lo YMD, Chu IMT, Tsai SN, Zhong MQ, Fung KP, Waye MMY, Tsui SKW, Ng KO, Shan ZX, Yang M, Wu YL, Lin ZY, Ngai SM
Journal nameClinical Chemistry
Year2004
Month1
Day1
Volume Number50
Issue Number6
PublisherAMER ASSOC CLINICAL CHEMISTRY
Pages1036 - 1042
ISSN0009-9147
eISSN1530-8561
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesMedical Laboratory Technology; MEDICAL LABORATORY TECHNOLOGY

Last updated on 2020-31-07 at 23:11